montelukast 4 MG Chewable Tablet
1 INDICATIONS AND USAGE Montelukast sodium tablets are a leukotriene receptor antagonist indicated for: Prophylaxis and chronic treatment of asthma in patients 12 months of age and older (1.1) . Acute prevention of exercise-induced bronchoconstriction (EIB) in patients 6 years of age and older (1.2) . Relief of symptoms of allergic rhinitis (AR): seasonal allergic rhinitis (SAR) in patients 2 years of age and older, and perennial allergic rhinitis (PAR) in patients 6 months of age and older ( 1.3 ). 1.1 Asthma Montelukast sodium tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older. 1.2 Exercise-Induced Bronchoconstriction (EIB) Montelukast sodium tablets are indicated for prevention of exercise-induced bronchoconstriction (EIB) in patients 6 years of age and older. 1.3 allergic rhinitis Montelukast sodium tablets are indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older.
Apotex Corp
Related Pills
montelukast 5 MG Chewable Tablet
Apotex Corp
montelukast 10 MG Oral Tablet
Apotex Corp
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Montelukast sodium chewable tablets, USP 4 mg, are pink, oval, biconvex chewable tablets, engraved with "APO" on one side and "M4" on the other side. The tablets may be mottled. They are supplied as follows: NDC 60505-3573-3 unit of use high-density polyethylene (HDPE) bottles of 30 with a polypropylene child-resistant cap with a triseal liner, a lift and peel induction seal, and silica gel desiccant NDC 60505-3573-9 unit of use high-density polyethylene (HDPE) bottles of 90 with a polypropylene child-resistant cap with a triseal liner, a lift and peel induction seal, and silica gel desiccant NDC 60505-3573-8 bulk packaging high-density polyethylene (HDPE) bottles of 1,000 with a non-child-resistant polypropylene cap with a triseal liner, a lift and peel induction seal, and silica gel desiccant. Montelukast sodium chewable tablets, USP 5 mg, are pink, round, biconvex chewable tablets, engraved with "APO" on one side and "M5" on the other side. The tablets may be mottled. They are supplied as follows: NDC 60505-3574-3 unit of use high-density polyethylene (HDPE) bottles of 30 with a polypropylene child-resistant cap with a triseal liner, a lift and peel induction seal, and silica gel desiccant NDC 60505-3574-9 unit of use high-density polyethylene (HDPE) bottles of 90 with a polypropylene child-resistant cap with a triseal liner, a lift and peel induction seal, and silica gel desiccant NDC 60505-3574-8 bulk packaging high-density polyethylene (HDPE) bottles of 1,000, with a non-child-resistant polypropylene cap with a triseal liner, a lift and peel induction seal, and silica gel desiccant. Montelukast sodium film-coated tablets, USP 10 mg, are beige, rounded square-shaped, biconvex film-coated tablets, engraved with "APO" on one side and "M10" on the other side. They are supplied as follows: NDC 60505-3562-3 unit of use high-density polyethylene (HDPE) bottles of 30 with a polypropylene child-resistant cap with a triseal liner, a lift and peel induction seal, and silica gel desiccant NDC 60505-3562-9 unit of use high-density polyethylene (HDPE) bottles of 90 with a polypropylene child-resistant cap with a triseal liner, a lift and peel induction seal, and silica gel desiccant NDC 60505-3562-8 bulk packaging high-density polyethylene (HDPE) bottles of 1,000, non-child-resistant polypropylene cap with a triseal liner, a lift and peel induction seal and silica gel desiccant. Storage Store montelukast 4 mg chewable tablets, 5 mg chewable tablets and 10 mg film-coated tablets at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from moisture and light. Store in original package. Storage for Bulk Bottles Store bottles of 1,000 montelukast 4 mg chewable tablets, 5 mg chewable tablets, and 10 mg film-coated tablets at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from moisture and light. Store in original container. When product container is subdivided, repackage into a well-closed, light-resistant container.
More pills like OVAL APO M4